CAS RN: 3034-47-7
2-CHLORO-5-NITROTHIAZOLE
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
97% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250717
250mg / 1g / 5g / 10g / 25g
Out of stock
8-10 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 5g
Available purity: >97%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 3034-47-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
5g
>97%
0
Out of Stock
Beijing
Inquiry
3034-47-7 / 2-chloro-5-nitro-1,3-thiazole
Standard CAS: 3034-47-7
Multi CAS: No
Basic Information
copy
CAS
3034-47-7 copy
Multi CAS
No copy
Molecular Formula
C3HCLN2O2S copy
Molecular Weight
164.570000 copy
Exact Mass
163.944726 copy
InChI
InChI=1S/C3HClN2O2S/c4-3-5-1-2(9-3)6(7)8/h1H copy
InChIKey
USOMXSLAPRWFCV-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
9 copy
Aromatic heavy atom count
5 copy
Rotatable bonds
1 copy
H-bond acceptors
4 copy
Molar refractivity
33.78 copy
TPSA
56.03 copy
LogP / Solubility
WLOGP
1.7 copy
MLOGP
1.5 copy
XLogP3
2.1 copy
Consensus LogP
1.77 copy
Log S (ESOL)
-2.28 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-2.14 copy
Class (Ali)
Moderately soluble copy
Log S (SILICOS-IT)
-2.26 copy
Class (SILICOS-IT)
Moderately soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-2.51 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
1.5 copy